OpenAI and Anthropic need money, but the market wants to see a successful IPO first / Photo: daily_creativity/Shutterstock.com
News·
OpenAI had to lower its target valuation from $1.4 trillion to $1.25 trillion. Where did all the hype go?
The announcement of new investments coincided with a visit by Nvidias CEO to Kazakhstan, where most of the Higgsfield engineering team is based / Photo: DIA TV / Shutterstock.com
News·
Kazakhstan's first "AI unicorn" has attracted investment from Nvidia
Investors punished Meta and other popular tech companies for their massive AI spending / Photo: Shutterstock.com
Review·
Top Stories This Morning: Investors Sold Off AI Stocks; SK Hynix Canceled Solidigm's IPO
Asian stocks took another hit amid concerns about the justification for spending by U.S. tech giants / Photo: Ned Snowman/Shutterstock.com
News·
Fears of an AI bubble have sent Asian stocks tumbling. Which assets are investors flocking to?
News·
Defying Wall Street: Why Bernstein Expects CoreWeave's Stock to Continue Plummeting
News·
L'Oréal's sales exceeded expectations. Has high-end cosmetics proven to be more resilient than luxury goods?
News·
French sovereign risk premium has hit eurozone crisis levels
News·
Cybersecurity stocks are rising due to a new threat. Which ones aren't too late to buy?
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Archer Aviation, valued at around $3 billion, is developing vertical takeoff and landing air taxis / Photo: www.archer.com
Small Caps·
Motley Fool: Six next-generation tech stocks not to forget amid the Anthropic IPO
Small Caps·
AI needs power and computing capacity: Three Griffin holdings with up to 400% upside
Small Caps·
Software maker Braze soars 50% as Salesforce agrees to buy it for $5.66 bln
Small Caps·
Memory stocks plunged as much as 25% last week. How to buy the dip.
Small Caps·
+1
·
Citrini bets on biotech after using Anthropic AI to design potential drug
Go to section

Investment and Finance News